The UK's Serious Fraud Office is investigating the 'commercial practices' of drug giant GlaxoSmithKline (GSK).
Investigators have confirmed that it has started a criminal investigation, but has not given any details other than to suggest that the source was a whistleblower. "Whistleblowers are valuable sources of information to the SFO in its cases," a statement says.
GSK staff are already under investigation of bribing government and hospital officials in China, and similar investigations are also underway in Poland and Iraq. Polish whistleblower Jarek Wisniewiski, a former GSK sales rep, claimed last April that the company had paid doctors to promote its asthma drug, Seretide.
(Source: BBC, 27 May, 2014)